Skip to content

Changes of Functional Connectivity After rTMS in Depression

Change of Dopamine Pathway After rTMS Treatment in Major Depressive Disorder

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01325831
Enrollment
44
Registered
2011-03-30
Start date
2009-05-31
Completion date
2011-06-30
Last updated
2012-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression

Brief summary

In order to explore the effect of repetitive TMS, which has shown to be effective in intractable depression, we will examine resting-state, default-mode network functional connectivity in patients with major depression. We will use a double-blind, sham-controlled design. Our target sample size is 60(30 patients will be treated by active rTMS, the other 30 will be treated by sham rTMS). We will apply 10-day course of 10 Hz rTMS on left dorsolateral prefrontal cortex of the subjects.

Detailed description

Up to now, 24 patients with major depression and 6 normal controls are enrolled. Twenty-three patients and 4 normal participants have taken 10 days rTMS. One patients and one control withdrew their consent without any reason and one control withdrew the consent because of headache. We scanned fMRIs(to examine functional connectivity)twice for each participant, which were taken 3 days before the first and 3 days after the last rTMS. All of participants have not reported side effects except mild headahe. There's been no seizure event up to now.

Interventions

10-day course of 10 Hz rTMS on left dorsolateral prefrontal cortex of the subjects.

DEVICESham repetitive transcranial magnetic stimulation(rTMS)

Sham repetitive transcranial magnetic stimulation(rTMS)

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* DSM-IV major depressive episode * Failure of at least 3 different kind of antidepressant

Exclusion criteria

* Organic brain disorder * Other diagnosis of DMS-IV except nicotine dependence * History of seizure disorder

Design outcomes

Primary

MeasureTime frame
change of functional connectivity between pre/post rTMS14 days

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026